Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease

[1]  L. Forsgren,et al.  Weight gain and increased central obesity in the early phase of Parkinson's disease. , 2014, Clinical nutrition.

[2]  C. Mariani,et al.  Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors. , 2014, Parkinsonism & related disorders.

[3]  Jungsu S. Oh,et al.  Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia , 2014, Neuroreport.

[4]  D. Dexter,et al.  Parkinson disease: from pathology to molecular disease mechanisms. , 2013, Free radical biology & medicine.

[5]  K. Flegal,et al.  Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories , 2012 .

[6]  Marco Pagani,et al.  No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers , 2013, NeuroImage.

[7]  B. Bloem,et al.  Body mass index in Parkinson's disease: a meta-analysis. , 2012, Parkinsonism & related disorders.

[8]  Dae Hyuk Moon,et al.  Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy , 2012, The Journal of Nuclear Medicine.

[9]  T. van Amelsvoort,et al.  Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects , 2011, EJNMMI research.

[10]  R. Honea,et al.  Alzheimer disease biomarkers are associated with body mass index , 2011, Neurology.

[11]  Graham K Kerr,et al.  Prevalence of malnutrition in Parkinson's disease: a systematic review. , 2011, Nutrition reviews.

[12]  D. Brooks,et al.  Serotonergic mediated body mass index changes in Parkinson's disease , 2011, Neurobiology of Disease.

[13]  Efstathios Manios,et al.  Association Between Obesity and Mortality After Acute First-Ever Stroke: The Obesity–Stroke Paradox , 2011, Stroke.

[14]  R. Walker,et al.  A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson's disease , 2010, BMC neurology.

[15]  E. Reisin,et al.  The Obesity Paradox and Cardiovascular Disease , 2010, Current hypertension reports.

[16]  V. Sossi,et al.  Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. , 2009, Brain : a journal of neurology.

[17]  R. Cottrell,et al.  A review and meta-analysis of the effect of weight loss on all-cause mortality risk , 2009, Nutrition Research Reviews.

[18]  M. Mazzola,et al.  Body mass index does not change before Parkinson’s disease onset , 2008, European journal of neurology.

[19]  V. Somers,et al.  Accuracy of body mass index in diagnosing obesity in the adult general population , 2008, International Journal of Obesity.

[20]  Claude Pichard,et al.  Prognostic impact of disease-related malnutrition. , 2008, Clinical nutrition.

[21]  M. Gail,et al.  Cause-specific excess deaths associated with underweight, overweight, and obesity. , 2007, JAMA.

[22]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  G Hu,et al.  Body mass index and the risk of Parkinson disease , 2006, Neurology.

[24]  C. Trenkwalder,et al.  Body weight in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[25]  Xiao-Bing Gao,et al.  Leptin Receptor Signaling in Midbrain Dopamine Neurons Regulates Feeding , 2006, Neuron.

[26]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[27]  Miguel A Hernán,et al.  Weight loss in Parkinson's disease , 2003, Annals of neurology.

[28]  S. B. Evans,et al.  Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat , 2003, Brain Research.

[29]  A. Fasano,et al.  Gastrointestinal dysfunction in Parkinson's disease , 2003, The Lancet Neurology.

[30]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[31]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.

[32]  C Bogardus,et al.  Energy balance and weight regulation: genetics versus environment , 2000, British Journal of Nutrition.

[33]  S. Coppack,et al.  Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. , 1999, American journal of physiology. Endocrinology and metabolism.

[34]  P. Ponikowski,et al.  Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. , 1999, European heart journal.

[35]  D J Brooks,et al.  Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. , 1996, Brain : a journal of neurology.

[36]  C. Power,et al.  Weight-for-height indices of adiposity: relationships with height in childhood and early adult life. , 1995, International journal of epidemiology.

[37]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[38]  A. Tomkins,et al.  Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. , 1992, Clinical science.

[39]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[40]  C. Sirtori,et al.  Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. , 1972, The New England journal of medicine.

[41]  N. Volkow,et al.  Food and drug reward: overlapping circuits in human obesity and addiction. , 2012, Current topics in behavioral neurosciences.

[42]  C. Hawkes,et al.  Olfaction in neurodegenerative disorder. , 2006, Advances in oto-rhino-laryngology.

[43]  B. Vellas,et al.  Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group). , 2005, The journal of nutrition, health & aging.

[44]  Jon T. Willie,et al.  To eat or to sleep? Orexin in the regulation of feeding and wakefulness. , 2001, Annual review of neuroscience.

[45]  A. Tomkins,et al.  Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters , 1993, Journal of neural transmission. Parkinson's disease and dementia section.